Endolymphatic Radiotherapy in Maglignant Lymphomas

¡ ¡
¡ Recent Results in Cancer Research āĻŦāχ 37 ¡ Springer Science & Business Media
āχ-āĻŦ⧁āĻ•
132
āĻĒ⧃āĻˇā§āĻ āĻž
āϰ⧇āϟāĻŋāĻ‚ āĻ“ āϰāĻŋāĻ­āĻŋāω āϝāĻžāϚāĻžāχ āĻ•āϰāĻž āĻšā§ŸāύāĻŋ  āφāϰāĻ“ āϜāĻžāύ⧁āύ

āĻāχ āχ-āĻŦ⧁āϕ⧇āϰ āĻŦāĻŋāĻˇā§Ÿā§‡

Clinical trials with Lipiodol l3ll were started in 1961 by my associate, S. CHIAPPA, and a group of physicians at the Institute of Radiology and the National Cancer Institute in Milan and development has been vigorously pursued during the past years. Once the rationale of this method was established, various aspects of the prob lem have been investigated, particularly the distribution of the radioactive dye into the lymph nodes as weIl as its fate and dosimetry in the body tissues. This mono graph describes the extensive clinical evaluation and the radiological results obtained in a large group of patients with malignant lymphomas. Endolymphatic radiotherapy as a therapeutic tool employing radiÃļnuclides has aroused interest at several meetings concerned with lymphology. In the re cent mono graph "Lymphography in cancer" by W. A. FUCHS, J. W. DAVIDSON and H. W. FISCHER, Dr. JANTET wrote a chapter on this specific subject. Many aspects are still debated, i. e. the choice of radionuclide, the specific clinical indications and the proper evaluation of the therapeutic effects. It is hoped that further studies will come to more precise conclusions.

āχ-āĻŦ⧁āϕ⧇ āϰ⧇āϟāĻŋāĻ‚ āĻĻāĻŋāύ

āφāĻĒāύāĻžāϰ āĻŽāϤāĻžāĻŽāϤ āϜāĻžāύāĻžāύāĨ¤

āĻĒāĻ āύ āϤāĻĨā§āϝ

āĻ¸ā§āĻŽāĻžāĻ°ā§āϟāĻĢā§‹āύ āĻāĻŦāĻ‚ āĻŸā§āϝāĻžāĻŦāϞ⧇āϟ
Android āĻāĻŦāĻ‚ iPad/iPhone āĻāϰ āϜāĻ¨ā§āϝ Google Play āĻŦāχ āĻ…ā§āϝāĻžāĻĒ āχāύāĻ¸ā§āϟāϞ āĻ•āϰ⧁āύāĨ¤ āĻāϟāĻŋ āφāĻĒāύāĻžāϰ āĻ…ā§āϝāĻžāĻ•āĻžāωāĻ¨ā§āĻŸā§‡āϰ āϏāĻžāĻĨ⧇ āĻ…āĻŸā§‹āĻŽā§‡āϟāĻŋāĻ• āϏāĻŋāĻ™ā§āĻ• āĻšā§Ÿ āĻ“ āφāĻĒāύāĻŋ āĻ…āύāϞāĻžāχāύ āĻŦāĻž āĻ…āĻĢāϞāĻžāχāύ āϝāĻžāχ āĻĨāĻžāϕ⧁āύ āύāĻž āϕ⧇āύ āφāĻĒāύāĻžāϕ⧇ āĻĒ⧜āϤ⧇ āĻĻā§‡ā§ŸāĨ¤
āĻ˛ā§āϝāĻžāĻĒāϟāĻĒ āĻ“ āĻ•āĻŽā§āĻĒāĻŋāωāϟāĻžāϰ
Google Play āĻĨ⧇āϕ⧇ āϕ⧇āύāĻž āĻ…āĻĄāĻŋāĻ“āĻŦ⧁āĻ• āφāĻĒāύāĻŋ āĻ•āĻŽā§āĻĒāĻŋāωāϟāĻžāϰ⧇āϰ āĻ“ā§Ÿā§‡āĻŦ āĻŦā§āϰāĻžāωāϜāĻžāϰ⧇ āĻļ⧁āύāϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤
eReader āĻāĻŦāĻ‚ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āĻĄāĻŋāĻ­āĻžāχāϏ
Kobo eReaders-āĻāϰ āĻŽāϤ⧋ e-ink āĻĄāĻŋāĻ­āĻžāχāϏ⧇ āĻĒāĻĄāĻŧāϤ⧇, āφāĻĒāύāĻžāϕ⧇ āĻāĻ•āϟāĻŋ āĻĢāĻžāχāϞ āĻĄāĻžāωāύāϞ⧋āĻĄ āĻ“ āφāĻĒāύāĻžāϰ āĻĄāĻŋāĻ­āĻžāχāϏ⧇ āĻŸā§āϰāĻžāĻ¨ā§āϏāĻĢāĻžāϰ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤ āĻŦā§āϝāĻŦāĻšāĻžāϰāĻ•āĻžāϰ⧀āϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ⧇ āϤ⧈āϰāĻŋ āϏāĻšāĻžā§ŸāϤāĻž āϕ⧇āĻ¨ā§āĻĻā§āϰāϤ⧇ āĻĻ⧇āĻ“ā§ŸāĻž āύāĻŋāĻ°ā§āĻĻ⧇āĻļāĻžāĻŦāϞ⧀ āĻ…āύ⧁āϏāϰāĻŖ āĻ•āϰ⧇ āϝ⧇āϏāĻŦ eReader-āĻ āĻĢāĻžāχāϞ āĻĒāĻĄāĻŧāĻž āϝāĻžāĻŦ⧇ āϏ⧇āĻ–āĻžāύ⧇ āĻŸā§āϰāĻžāĻ¨ā§āϏāĻĢāĻžāϰ āĻ•āϰ⧁āύāĨ¤